Theralink Technologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Theralink Technologies generated cash of -$4,780,930, which is less than the previous year. Cash used in financing activities reached the amount of $3,450,000 last year. Net change in cash is therefore -$1,465,132.
Cash Flow
| 2012 | -606.15K | 64.9K | 250K |
|---|---|---|---|
| 2013 | -637.62K | 891.96K | 0 |
| 2014 | -372.22K | -152.3K | 25K |
| 2016 | -1.54M | 0 | 871.23K |
| 2018 | -1.67M | 0 | 1.67M |
| 2020 | -3.47M | 144.39K | 4.54M |
| 2021 | -4.78M | -134.20K | 3.45M |
OBMP Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2018 | 2016 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.77M | 560.40K | 1.43K | 672.76K | 512.48K | 258.14K | 549.39K |
Operating activities | |||||||
Net income | -5.47M | -3.17M | 6.46M | -2.01M | -757.40K | -315.93K | -952.54K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 185.73K | 97.76K | 2.33K | 1.09K | 17.44K | 86.48K | 88.28K |
Stock-based compensation expense | 0 | 0 | 329.41K | 89.82K | 0 | 132.13K | 213.91K |
| Deferred income tax benefit | 0 | 0 | 329.41K | 89.82K | 0 | 132.13K | 213.91K |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 15.87K | -51.55K |
Inventories | 273 | 0 | 0 | 0 | 0 | 2.16K | 15.00K |
Accounts payable | 415.19K | 46.34K | 172.06K | 111.34K | 0 | 0 | 0 |
Cash generated by operating activities | -4.78M | -3.47M | -1.67M | -1.54M | -372.22K | -637.62K | -606.15K |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -135.70K | -531.53K | 0 | 0 | -102.3K | 0 | 0 |
Acquisitions Net | 1K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -134.20K | 144.39K | 0 | 0 | -152.3K | 891.96K | 64.9K |
Financing activities | |||||||
Common Stock Issued | 1.35M | 0 | 6K | 534.42K | 75K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -24.75K | -415.84K | -46.13K | -200K | 0 | 0 |
Cash used in financing activities | 3.45M | 4.54M | 1.67M | 871.23K | 25K | 0 | 250K |
Net Change In Cash | -1.46M | 1.21M | -1.23K | -672.76K | -499.52K | 254.34K | -291.25K |
Cash at end of period | 314.15K | 1.77M | 201 | 0 | 12.95K | 512.48K | 258.14K |
| Data source | Data source |